Skip to search formSkip to main contentSkip to account menu

mozavaptan

Known as: N-(4-(((5RS)-5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methylbenzamide 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

BenzazepinesVasopressin Antagonist

Narrower (2)

OPC 31260mozavaptan hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Imidafenacin exerts the antidiuretic effect by enhancing vasopressin-related responses in orally water-loaded rats.
Review
2013
Review
2013
Vaptans: a novel class of drugs causing free water diuresis
>> We read with interest the recent review on diuretics. 1 The author comprehensively discussed types of diuretics, their… 
Review
2012
Review
2012
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
Dilutional hyponatremia is the most common electrolyte disorder occurring in heart failure (HF). The relation between… 
2011
2011
Improved synthesis of mozavaptan
Mozavaptan(1),a new type of vasopressin V2 receptor antagonist,has been used for the treatment of hyponatremia caused by heart… 
2011
2011
DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR ESTIMATION OF MOZAVAPTAN IN HUMAN PLASMA USING LC-MS/MS
A simple, accurate liquid chromatography with tandem mass spectrometry (LC/MS-MS) method has been developed and validated in… 
Review
2010
Review
2010
[Vasopressin receptor antagonists: the vaptans].
Review
2009
Review
2009
New topics in vasopressin receptors and approach to novel drugs: preface.
Arginine vasopressin (AVP) is a cyclic nonapeptide that is centrally synthesized in the hypothalamus. Vasopressin has a plethora… 
Review
2009
Review
2009
Introduction: vasopressin therapy
Hyponatremia, generally defined as a serum sodium level below 130–135 mEq/L, is the most common electrolyte abnormality in… 
Review
2008
Review
2008
Treatment of Hyponatremia in Cirrhosis
Letter to the Editor In his review article, Dr. Mahesh [1] discussed the pathophysiology and management of hyponatremia in… 
2003
2003
Mozavaptan promising in polycystic kidney disease
  • 2003
  • Corpus ID: 195125789
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)